This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
18 Sep 2025

Reptile Gel as a Non-Invasive Topical Therapy for Erectile Dysfunction: Findings from the First Clinical Trial and Future Directions of WBCIL

Reptile Gel, a topical product by WBCIL, India, treats erectile dysfunction (ED) by enhancing penile blood flow via cooling and warming, promoting vasodilation. USFDA-approved as OTC, it has no side effects, offering a safe alternative to PDE5 inhibitors. Formulated with ethanol, propylene glycol, glycerin, and carbomer, it absorbs quickly. A trial showed biphasic thermal response; ongoing studies assess vascular effects via Doppler ultrasound. CE-compliant under EU MDR, it improves hemodynamics, confidence, and relationships discreetly.

Reptile gel clinical trial-1

Mentioned Companies
West Bengal Chemical Industries Limited
View company profile